FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

5040011000001109: Graphite 30c homeopathic tablets (Weleda (UK) Ltd) 125 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
27185101000001116 Graphite 30c homeopathic tablets (Weleda (UK) Ltd) 125 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
27185201000001111 Graphite 30c homeopathic tablets (Weleda (UK) Ltd) 125 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Graphite 30c homeopathic tablets (Weleda (UK) Ltd) 125 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Graphite 30c homeopathic tablets (Weleda (UK) Ltd) 125 tablet Is a Graphites 30c homeopathic tablets 125 tablet true Inferred relationship Existential restriction modifier
Graphite 30c homeopathic tablets (Weleda (UK) Ltd) 125 tablet Is pack of Graphite 30c homeopathic tablets (Weleda (UK) Ltd) false Inferred relationship Existential restriction modifier
Graphite 30c homeopathic tablets (Weleda (UK) Ltd) 125 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Graphite 30c homeopathic tablets (Weleda (UK) Ltd) 125 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Graphite 30c homeopathic tablets (Weleda (UK) Ltd) 125 tablet Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Graphite 30c homeopathic tablets (Weleda (UK) Ltd) 125 tablet Legal category General sales list true Inferred relationship Existential restriction modifier
Graphite 30c homeopathic tablets (Weleda (UK) Ltd) 125 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Graphite 30c homeopathic tablets (Weleda (UK) Ltd) 125 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Graphite 30c homeopathic tablets (Weleda (UK) Ltd) 125 tablet Has manufactured dose form Homeopathic tablet false Inferred relationship Existential restriction modifier
Graphite 30c homeopathic tablets (Weleda (UK) Ltd) 125 tablet Has active ingredient Alternative medicine agent false Inferred relationship Existential restriction modifier
Graphite 30c homeopathic tablets (Weleda (UK) Ltd) 125 tablet Has AMP Graphite 30c homeopathic tablets (Weleda (UK) Ltd) true Inferred relationship Existential restriction modifier
Graphite 30c homeopathic tablets (Weleda (UK) Ltd) 125 tablet Has dispensed dose form Homeopathic tablet true Inferred relationship Existential restriction modifier
Graphite 30c homeopathic tablets (Weleda (UK) Ltd) 125 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Graphite 30c homeopathic tablets (Weleda (UK) Ltd) 125 tablet Discontinued indicator Discontinued AMPP(qualifier value) false Inferred relationship Existential restriction modifier
Graphite 30c homeopathic tablets (Weleda (UK) Ltd) 125 tablet Discontinued indicator Re-marketed true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start